CRGT (Cortigent, Inc.) Sof daromad

FDA klinik sinovlar bosqichi tufayli narxlarni belgilash imkoniyatining yetishmasligi Cortigent, Inc. (CRGT) kompaniyasining joriy daromadlarini cheklamoqda. Ushbu grafikdagi kompaniyaning sof foydasi zarur tadqiqot resurslari taqdim etilgan nufuzli neyrostimulyator muhandislarining natijalarini aks ettiradi. Biroq, biznes chiplarni yig'ishda tashqi pudratchilarga tayanadi. Oxirgi qiymat deb qayd etilgan bo'lib, bu emitentning uzoq muddatli rivojlanish vektorini baholash imkonini beradi.

Kompaniyaning sof foydasi: Cortigent Medical (CRGT) 04.07.2022 - 30.10.2026 uchun

cortigent.com (CRGT) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Cortigent|CRGT - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor bahosi CRGT|CRGT - Kompaniyaning to‘liq qiymati
- kompaniyaning balans qiymati tafsilotlari:
Bitta aksiya hisobiga sof aktivlar qiymati Cortigent|CRGT - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati cortigent.com|CRGT - Kompaniyaning yakuniy aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Jamlagan qarzning kapitalga nisbati Cortigent, Inc.|CRGT - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Cortigent|CRGT - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati CRGT|CRGT - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Cortigent|Shoshilinch likvidlik koeffitsiyenti cortigent.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
CRGT - Sof daromad
Fundamental baholash:CRGT (Cortigent Medical)

Ushbu ko'rsatkich barcha operatsion va soliq xarajatlarini chegirib tashlagandan keyingi mablag'larning sof balansini o'lchaydi, bu esa bozor kutuvlariga zid ravishda biznesning yashab qolish qobiliyatini ob'ektiv baholash imkonini beradi. Kompaniyaning moliyaviy natijalari tarixini tahlil qilish orqali investor foyda barqarorligini aniqlaydi, bu esa Cortigent, Inc. (CRGT) holatida neyron implant xizmatlariga bo'lgan uzoq muddatli talab bilan ta'minlanib, kapitalning doimiy oqimini kafolatlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof daromad regencellbioscience.com (RGC)|Kompaniyaning sof foydasi Axsome Therapeutics, Inc. (AXSM)|ACAD - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|Yakuniy foyda VKTX|SUPN: Sof daromad|catalystpharma.com - Soliqlar to‘langandan keyingi foyda|DNLI: Sof foyda|HRMY - Sof moliyaviy natija|BHVN (Biohaven Pharmaceutical) - Sof foyda|AMLX - Yillik sof foyda|Sof foyda TRVI|PRAX - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Anavex Life Sciences Corp. AVXL|CBLL: Kompaniya foydasi|PRTA: Sof daromad|Alector, Inc. - Soliqlar to‘langandan keyingi foyda|ANNX (Annexon, Inc.) - Sof daromad|Omeros - Yakuniy foyda|NGNE (Neurogene) - Sof foyda|AC Immune S.A. (ACIU) - Sof moliyaviy natija|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|Neumora Corp - Kompaniya foydasi|Sof foyda SCLX (Scilex Holding Company)|TVGN - Sof daromad|ACOG: Sof daromad|Sof moliyaviy natija cogrx.com CGTX|IKT: Sof foyda|Sof daromad Cassava Pharma|Kompaniyaning sof foydasi Assertio Holdings|COYA: Yakuniy foyda|Sof foyda VTGN|ovidrx.com (OVID) - Yillik sof foyda|Acumen Pharma - Sof daromad|Soliqlar to‘langandan keyingi foyda CRVO (CervoMed Corporation)|ATHE - Kompaniyaning sof foydasi|CLNN (Clene Inc.) - Kompaniya foydasi|PEPG: Sof foyda|Kompaniyaning sof daromadi jupiterneurosciences.com (JUNS)|Sof daromad RLMD|Sof foyda Annovis Bio Corporation|Kompaniyaning sof foydasi Grace Therapeutics, Inc. (GRCE)|AIFF (fireflyneuro.com) - Yakuniy foyda|Kompaniyaning sof foydasi Klotho Neurosciences KLTO|NeuroSense Therapeutics Ltd (NRSN) - Kompaniyaning sof daromadi|Reviva Pharmaceuticals Holdings - Sof foyda|MetaVia Inc (MTVA) - Sof daromad|NeurAxis, Inc. (NRXS) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Helius Medical Technologies (HSDT)|Kompaniyaning sof foydasi Passage Bio Inc.|NEUP: Yakuniy foyda|Sof daromad NERV (Minerva Neurosciences Corp)|Soliqlar to‘langandan keyingi foyda ATHA|Sof foyda ADXN (Addex Therapeutics)|Sof moliyaviy natija Alzamend Neuro Inc. (ALZN)|Cyclerion - Sof foyda|Yillik sof foyda Protagenic Therapeutics (PTIX)|KTTA: Sof foyda|Kompaniyaning sof daromadi Avenue Therapeutics Inc (ATXI)|Kompaniyaning sof foydasi Brainstorm Cell|Kompaniya foydasi CARA (caratherapeutics.com)|Sof daromad CHRO (Chromocell Therapeutics Corp.)|Soliqlar to‘langandan keyingi foyda ELYM|Intra-Cellular Therapies, Inc. - Sof daromad|Yakuniy foyda LBPH|Marinus Pharmaceuticals - Sof foyda|Sof moliyaviy natija nkgenbiotech.com NKGN|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|Kompaniya foydasi SAGE|SNPX (Neurotrope) - Sof foyda|Sof daromad Trevena Inc (TRVN)|Sof daromad VIGL (Vigil Neuroscience)|Sof moliyaviy natija Anew Medical Inc.|Sof foyda CERE (Cerevel Therapeutics, Inc.)